Zhongzhi Pharmaceutical Holdings (HKSE:03737) Market Cap : HK$759 Mil (As of Mar. 29, 2025)

View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zhongzhi Pharmaceutical Holdings's share price for the quarter that ended in Jun. 2024 was HK$1.25. Zhongzhi Pharmaceutical Holdings's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 845 Mil. Therefore, Zhongzhi Pharmaceutical Holdings's market cap for the quarter that ended in Jun. 2024 was HK$1,057 Mil.

Zhongzhi Pharmaceutical Holdings's quarterly market cap increased from Jun. 2023 (HK$932 Mil) to Dec. 2023 (HK$1,203 Mil) but then declined from Dec. 2023 (HK$1,203 Mil) to Jun. 2024 (HK$1,057 Mil).

Zhongzhi Pharmaceutical Holdings's annual market cap increased from Dec. 2021 (HK$839 Mil) to Dec. 2022 (HK$923 Mil) and increased from Dec. 2022 (HK$923 Mil) to Dec. 2023 (HK$1,203 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zhongzhi Pharmaceutical Holdings's Enterprise Value for Today is HK$929 Mil.

Zhongzhi Pharmaceutical Holdings Market Cap Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Market Cap Chart

Zhongzhi Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

1,075.02

1,380.63

838.53

923.23

1,202.74

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Market Cap	Get a 7-Day Free Trial															830.06	923.23	931.70	1,202.74	1,056.63

Competitive Comparison of Zhongzhi Pharmaceutical Holdings's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhi Pharmaceutical Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongzhi Pharmaceutical Holdings's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhi Pharmaceutical Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Zhongzhi Pharmaceutical Holdings's Market Cap falls into.

Save Embed

;

Save Embed

;

Zhongzhi Pharmaceutical Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Zhongzhi Pharmaceutical Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	HK$1.42	*	846.999
	=	HK$1,203

Zhongzhi Pharmaceutical Holdings's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )	=	Share Price (Q: Jun. 2024 )	*	Shares Outstanding (EOP) (Q: Jun. 2024 )
	=	HK$1.25	*	845.300
	=	HK$1,057

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Zhongzhi Pharmaceutical Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhi Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Market Cap

Traded in Other Exchanges

N/A

Address

No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN

Website

https://www.zeus.cn

Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.

Executives

Jiang Li Xia	2202 Interest of your spouse
Lai Zhi Tian	2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited	2101 Beneficial owner
Cheng Jin Le	2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited	2101 Beneficial owner
Novich Positioning Investment (cayman) Limited	2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership	2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings Headlines

No Headlines